Q3 FY2026 · ended Sep 26, 2026 · Revenue $12.14B, +9.1% YoY · Filed Oct 30, 2026
Thermo Fisher Scientific Inc. (TMO) files with the SEC under industry code 3829, Measuring & Controlling Devices, NEC. In Q3 of fiscal 2026, the quarter ended Sep 26, 2026, it reported revenue of $12.1 billion and net income of $1.7 billion. Free cash flow was $2.1 billion. As of Sep 26, 2026 it held $6.1 billion in cash and investments and $41.4 billion in total debt.
Revenue
$12.14B
+9.1% vs year-ago quarter
Net income
$1.72B
+6.5% vs year-ago quarter
Operating cash flow
$2.55B
+13.9% vs year-ago quarter
Free cash flow
$2.11B
+15.1% vs year-ago quarter
EPS
$4.64
+8.7% vs year-ago quarter
Dividend per share
$0.47
+9.3% vs year-ago quarter
Shares outstanding
370.52M
-1.4% vs year-ago quarter
Net cash
$-35.31B
Q3 FY2026
Operating margin
17.9%
TTM
Company profile
- Industry
- Measuring & Controlling Devices, NEC (SIC 3829)
- Listed as
- TMO (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 97745
- Former names
- THERMO ELECTRON CORP (until Nov 3, 2006)
Other Measuring & Controlling Devices, NEC companies
- Rockwell Automation, Inc ROK
- Trimble Inc. TRMB
- Onto Innovation Inc. ONTO
- Mirion Technologies, Inc. MIR
- Quantum-Si Inc QSI
- Owlet, Inc. OWLT
- Geospace Technologies Corp GEOS
- Birchtech Corp. BCHT
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 26, 2026 |
Q2 FY2026 Jun 27, 2026 |
Q1 FY2026 Mar 28, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 27, 2025 |
|---|---|---|---|---|---|
| Revenue | $12.1B | $12.0B | $11.0B | $12.2B | $11.1B |
| Operating income | $2.3B | $2.1B | $1.9B | $2.3B | $1.9B |
| Net income | $1.7B | $1.7B | $1.7B | $2.0B | $1.6B |
| Diluted EPS | $4.64 | $4.68 | $4.43 | $5.20 | $4.27 |
| Operating cash flow | $2.5B | $2.1B | $1.2B | $3.5B | $2.2B |
| Free cash flow | $2.1B | $1.7B | $816.0M | $3.0B | $1.8B |
| Total assets | $114.2B | $113.2B | $113.3B | $110.3B | $103.0B |
| Stockholders' equity | $54.8B | $52.7B | $51.9B | $53.4B | $51.0B |
| Cash and investments | $6.1B | $4.1B | $3.3B | $10.1B | $3.5B |
| Total debt | $41.4B | $42.5B | $43.2B | $40.9B | $35.7B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 30, 2026 | Oct 27, 2026 |
| 10-Q | Quarterly report | Oct 30, 2026 | Sep 26, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 21, 2026 | Oct 21, 2026 |
| 10-Q | Quarterly report | Jul 31, 2026 | Jun 27, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 23, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 26, 2026 | May 20, 2026 |
All 1001 Thermo Fisher Scientific Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.